2newcw11 thefan-am1090seattle-logo-fina2l
SUBWAY BEAST MODE CHALLENGE 2014 | Sign up for our 3.5-mile adventure run | INFO |

News

FDA Warning Might Be Cited In Afghan Slayings Case

View Comments
In this picture taken on March 11, 2012, an Afghan villager points to a spot where a family was shot, allegedly by US soldier Staff Sergeant Robert Bales. (Photo by Mamoon Durrani/AFP/Getty Images)

In this picture taken on March 11, 2012, an Afghan villager points to a spot where a family was shot, allegedly by US soldier Staff Sergeant Robert Bales. (Photo by Mamoon Durrani/AFP/Getty Images)

News

Get Breaking News First

Receive News, Politics, and Entertainment Headlines Each Morning.
Sign Up

SEATTLE (AP) — A lawyer for an American soldier set to be sentenced for killing 16 Afghan civilians may cite a new Food and Drug Administration warning about the psychiatric side effects of an anti-malarial drug used by U.S. troops.

On Monday, the FDA said mefloquine (MEF-loe-kwin) — known as Lariam, its brand name — can cause long-term neurological damage and serious psychiatric side effects.

Attorney John Henry Browne has said he has documents indicating his client, Staff Sgt. Robert Bales, took the drug while in Iraq, but medical records for his time in Afghanistan are incomplete.

Browne told The Seattle Times ( http://tinyurl.com/m4vqqtu ) the FDA warning was an interesting development.

Bales pleaded guilty to the 2012 killings last month. A jury will decide in August whether the soldier is sentenced to life with or without the possibility of parole.

(© Copyright 2013 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 1,080 other followers